Daiichi Sankyo CEO made NPC chair
This article was originally published in Scrip
The National Pharmaceutical Council (NPC) has elected John Gargiulo, president and CEO of Daiichi Sankyo, chair of board for 2012-13. Mr Gargiulo has served on NPC's board since 2007, most recently as vice-chair. The NPC is a health policy research organization dedicated to the advancement of good evidence and science.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.